France's Valneva expects recommendation on COVID-19 vaccine by end-March
Valneva expects to start delivering its vaccine in Europe soon after it is recommended for conditional approval by the end of March, the French vaccine maker said on Friday as it received an initial regulatory assessment. Valneva has received a list of questions on its VLA2001 vaccine from the Committee for Medicinal Products for Human Use (CHMP) and should respond in the coming days, it said
View the full story here: https://www.reuters.com/business/healthcare-pharmaceuticals/frances-valneva-expects-recommendation-covid-19-vaccine-by-end-march-2022-02-25/